期刊文献+

综合干预对老干部血脂情况的影响

下载PDF
导出
摘要 目的:分析近5年来,药物使用、合理膳食及适当运动等干预方式对老干部血脂达标情况的影响。方法:与南京军区南京总医院保健科合作,对辖区内9个干休所476名离休干部5年来的体检资料进行回顾性调查,并对部分老干部进行问卷调查。结果:①本研究人群血脂的基线水平为:TC(5.57±1.45)mmol/L、LDL-C(3.61±1.15)mmol/L、TG(2.06±1.07)mmol/L,经5年综合干预后,三者分别下降为(4.65±1.02)、(2.76±1.07)、(1.78±0.68)mmol/L,下降显著。其中,TG的变化显著(P<0.05),TC及LDL-C的变化非常显著(P<0.01)。②人群血脂达标的基线水平为:TC31.3%、LDL-C44.8%、TG56.7%,经干预后分别上升为56.8%、63.3%、68.6%,上升非常显著(P<0.01)。结论:他汀类药物的服用及合理膳食教育等综合干预,能够使血脂显著下降,达标率显著提高。
出处 《中国医药导报》 CAS 2007年第09Z期110-111,共2页 China Medical Herald
  • 相关文献

参考文献1

二级参考文献10

  • 1Slamler J, Wentworth D, Neaton JD. Is relationship between serum cholesterol a nd risk of premature death from coronary heart disease continuous and graded ? F indings in 356,222 primary screenees of the Multiple Risk Factor Intervention Tr ial (MRFIT). JAMA, 1986,256:2823-2828.
  • 2Castelli WP, Garrison RJ,Wilson PwF, et al. Incidence of coronary heart disea se and lipoprotein cholesterol levels: the Framing ham Study. JAMA, 1986, 256:28 35-2838.
  • 3Randomized trial of cholesterol lowering in 4,444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study(4S).Lancet,1994,344:1383 -1389.
  • 4Frick MH, Elo O, Haapa K, et al. Helsinki Heart Study: primary- prevention t ri al with gemfibrozil in middle-aged men with dislipidemia. Safety of treatment ,c hages in risk factors, and incidence of coronary heart disease. N Engl J Med, 1 987,317:1237-1245.
  • 5Shepherd J, Cobbe SM, Ford I, et al. Prevention of coronary heart disease wit h pravastatin in men with hypercholesterolemia. West of Scotland Coronary Preven tion Study Group. N Engl J Med,1995,333:1301-1307.
  • 6Downs JR, Clearfield M, Weis S, et al. Primary prevention of acute coronary e v ents with lovastatin in men and women with average cholesterol levels: results o f AFCAPS/TexCAPS. Air Force/Texas Coronary Artherosclerosis Prevention Study. JAMA .1998;279:1615-1622.
  • 7Summary of the second report of the National Cholesterol Education Program (NC EP) Expert Panel on Detection, Evaluation and Treatment of High Blood Cholestero l in Adults ( Adult Treatment Panel II Report). JAMA, 1993, 269:3015-3023.
  • 8Report of the National Cholesterol Education Program Expert Panel on Detection , Evaluation, and Treatment of High Blood Cholesterol in Adults. The Expert Pan el. Arch Intern Med, 1998, 148:36-69.
  • 90 Pearson TA, Laurora I, Chu H, et al. The lipid treatment assessment project (L -TAP):a multicenter survey to evaluate the percentages of dyslipidemic patients receiving lipid-lowering therapy and achieving low-density lipoprotein choles terol goals. Arch Intern Med, 2000, 160:459-467.
  • 10方圻,王钟林,宁田海,邵耕,陈在嘉,陆宗良,李健斋,林传骧,周北凡,诸骏仁,诸永康,陶萍,陶寿淇,龚兰生,顾复生,游凯,戴玉华.血脂异常防治建议[J].中华心血管病杂志,1997,25(3):169-175. 被引量:3067

共引文献175

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部